The X-Ray Reinvented
Our proprietary, advanced emitter technology platform – Quastar® produces high output and high quality photons more efficiently allowing our partners to improve our quality of life.


Life, it matters to us.
Rad Source irradiator solutions impact the lives of people across the world daily. From improving transplant patient outcomes, advancing cancer and cell research or helping control populations of disease-carrying and crop-destroying insects – Life matters.
What’s the Difference?
Quastar® vs. Traditional X-ray Imaging Tube
When it comes to x-ray field output, beam hardness, uniformity and versatility, the Quastar x-ray emitter is second to none. Quastar’s proprietary technology provides the ability to produce a greater photon flux of higher energy x-rays while filtering the weak x-rays that cause uneven dose treatment.
Quastar’s engineering provides faster, higher quality, and more uniform dosing of the target than the standard imaging tube, and it does so more efficiently.
What’s the Difference?
Quastar vs. Nuclear
Although a reactive source, nuclear radiation has been around for years due to its ease of availability. As technology matured, experts understood and acted on the effects of gamma ionizing radiation. From its volatility to harmful byproducts and stringent licensing requirements, gamma irradiation is becoming a thing of the past.
The Department of Energy has spearheaded CIRP (Cesium Irradiator Replacement Program) – a subsidizing initiative created to replace gamma isotope-source (cesium-137 based) irradiators in the US. They provide an up-to 50% financial incentive towards the purchase of a new non-radio isotopic device as well as the removal and disposal of current irradiator – an approximate cost-reduction of more than $200 thousand dollars.
By 2025, gamma powered irradiators will become obsolete. Stay ahead of the inevitable with us as we propel our global partners to improve and enhance the quality of life.
Latest News & Studies
Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR
Abstract: Common chromosomal fragile sites are unstable genomic loci susceptible to breakage, rearrangement, and are highly recombinogenic. Frequent alterations at these loci in tumor cells led to the hypothesis that they may...
The Sesquiterpene Lactone Parthenolide Induces Apoptosis of Human Acute Myelogenous Leukemia Stem and Progenitor Cells
Abstract: Recent studies have described malignant stem cells as central to the initiation, growth, and potential relapse of acute and chronic myelogenous leukemia (AML and CML). Because of their important role in pathogenesis,...
Passive and Active Mechanisms Trap Activated CD8+ T Cells in the Liver
Abstract: The liver is a site where activated CD8(+) T cells are trapped and destroyed at the end of an immune response. The intrahepatic accumulation of activated murine TCR transgenic CD8(+) T cells was significantly reduced...